They include an increase of hepcidin in the brain in a murine model of cerebral ischemia (Ding et al., 2011), and a reduction of both ferroportin and hepcidin detected in lysates obtained from AD patients (Raha et al., 2013). This evidence concerns the gene HAMP and Alzheimer disease.